Volume 12, Number 4—April 2006
Letter
Pulmonary Tuberculosis and SARS, China
Wei Liu*, Arnaud Fontanet†, Pan-He Zhang*, Lin Zhan*, Zhong-Tao Xin‡, Fang Tang*, Laurence Baril†, and Wu-Chun Cao*
Table
Demographic and clinical information on severe acute respiratory syndrome (SARS) patients with pulmonary tuberculosis (TB), Beijing, China, 2003
| Demographic/clinical characteristic | Patient 1 | Patient 2 | Patient 3 |
|---|---|---|---|
| Sex | M | M | M |
| Age (y) | 48 | 18 | 20 |
| Other coexisting conditions | Pseudomonas aeruginosa infection | None | None |
| Date of SARS onset | Apr 5, 2003 | Apr 7, 2003 | Apr 4, 2003 |
| Date of TB diagnosis | Jun 12, 2003 | Jan 24, 2003 | Mar 5, 2003 |
| Date of hospitalization or transfer to SARS ward | Apr 7, 2003 | Apr 7, 2003 | Apr 5, 2003 |
| Leukocyte count at admission, /μL | 12,500 | 6,800 | 2,500 |
| Total steroid dose used, mg | 25,280 | 2,600 | 3,600 |
| Intensive care unit admission | Yes | No | No |
| CD4/CD8 cell ratio 6 mo after disease | 0.63 | 1.56 | 1.23 |
| Absolute CD4 cell count 6 mo after disease, /μL | 368 | 431 | 306 |
| Absolute lymphocyte count 6 mo after disease, /μL | 2,098 | 1,115 | 1,666 |
Page created: January 23, 2012
Page updated: January 23, 2012
Page reviewed: January 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.